Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical students

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 12, 2008, Pages 1407-1413

  Teixeira, Eleny Guimarães ^a,b,c,f   Kritski, A ^c   Ruffino Netto, A ^d   Steffen, R ^b   Lapa E Silva, J R ^c   Belo, M ^a,b   Luiz, R R ^c   Menzies, D ^e   Trajman, A ^a  

^a GAMA FILHO UNIVERSITY   (Brazil)

^b Souza Marques Foundation   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e MCGILL UNIVERSITY   (Canada)

^f NONE   (Brazil)

Author keywords

BCG; Booster; Medical students; Tuberculin test; Tuberculosis

Indexed keywords

BCG VACCINE;

ADULT; ARTICLE; BCG VACCINATION; BOOSTER PHENOMENON; BRAZIL; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL STUDENT; PREVALENCE; PRIORITY JOURNAL; TUBERCULIN TEST;

BCG VACCINE; BRAZIL; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; STUDENTS, MEDICAL; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION; YOUNG ADULT;

EID: 58049190876     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva, Switzerland: WHO, 2007.
2. Ministério da Saúde. Sistema Informação de Agravos de Notificação. Brasilia, Brasil. http://dtr2004.saude.gov. br/sinanweb/novo/ Accessed February 2008. [Brazilian]
3. a EXPOEPI 2007; 56-57. [Brazilian]
4. Sepkowitz K A. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med 1994; 120: 71-79.
5. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005; 172: 1169-1227.
6. Jensen P A, Lambert L A, Iademarco M F, Ridzon R, CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care settings, 2005. MMWR Recomm Rep 2005; 54: 1-141.
7. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion and reversion. Am J Respir Crit Care Med 1999; 159: 15-21.
8. Menzies R, Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145: 621-625.
9. Ministério da Saúde, Secretaria de Vigilância em Saúde. Programa Nacional de Imunizações, 30 anos. Série C. Projetos e Programas e Relatórios. Brasília, Brazil: Ministério da Saúde, 2003: p 212. [Brazilian]
10. Ministério da Saúde, Secretaria de Vigilância em Saúde. Departemento de Vigilância Epidemiológica. Coordenação Geral do Programa Nacional do Programa de Imunizações. Nota técnica no 66/CGPNI/DEVEP/SVS/MS. Suspensão do uso da segunda dose da vacina BCG-ID do calendário de vacinação. Brasília, Brazil: Ministério da Saúde, 2006: p 5. [Brazilian]
11. Gontijo Filho P P, Christovão E D M. Estimativa da prevalência de infecções micobaterianas em escolares na Guanabara, através de testes intradérmicos com PPD-RT 23 e PPD-B. Rev Soc Bras Med Trop 1975; IX: 157-162. [Brazilian]
12. Bierrenbach A L, Floyd S, Cunha S C, et al. A comparison of dual skin test with mycobacterial antigens and tuberculin skin test alone in estimating prevalence of Mycobacterium tuberculosis infection from population surveys. Int J Tuberc Lung Dis 2003; 7: 312-319.
13. Silva V M, Cunha A J, Oliveira J R, et al. Medical students at risk of nosocomial transmission of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2000; 4: 420-426.
14. Ferreira F M. Freqüência de infecção por Mycobacterium tuberculosis em alunos do curso de graduação em Medicina da Universidade do Rio de Janeiro [Dissertação de Mestrado]. Rio de Janeiro, Brazil: Universidade Federal do Rio de Janeiro, 1998: p 110. [Brazilian]
15. Costa P A, Pessoa C L C, Kritski A L. Tuberculosis infection among medical students in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2001; 5 (Suppl 1): S208.
16. Hohmuth B A, Yamanija J C, Dayal A S, Nardell E, Salazar J J, Smith Fawzi M C. Latent tuberculosis infection: risks to health care students at a hospital in Lima, Peru. Int J Tuberc Lung Dis 2006; 10: 1146-1151.
17. Lainez R M, Cònsul M, Olona M, Martínez-Ballarín J I, Miravitlles M, Vidal R. Tuberculous infection in nursing students: prevalence and conversion during a 3-year follow-up. Med Clin (Barc) 1999; 113: 685-689.
18. Hizel K, Maral I, Karakus R, Aktas F. The influence of BCG immunisation on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis. Clin Microbiol Infect 2004; 10: 980-983.
19. Valenti W M, Andrews B A, Presley B A, Reifler C B. Absence of the booster phenomenon in serial tuberculin skin testing. Am Rev Respir Dis 1982; 125: 323-325.
20. Teixeira E G, Menzies D, Comstock G W, et al. Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis 2005; 9: 841-847.
21. Secretaria de Estado de Saúde do Rio de Janeiro. Dados da tuberculose no Estado do Rio de Janeiro. Rio de Janeiro, Brazil: Secretaria de Estado de Saúde do Rio de Janeiro. http://www.saude.rj.gov.br/ tuberculose/ Accessed June 2004. [Brazilian]
22. Associação Brasileira de Empresas de Pesquisa. Critério de Classificação Econômica Brasil. São Paulo, Brazil: ABEP, 2003. http://www.abep.org Accessed June 2008. [Brazilian]
23. Thompson N J, Glassroth J L, Snider D E, Farer L S. The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1979; 119: 587-597.
24. Menzies D. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Clin Infect Dis 2000; 31 (Suppl 3): S71-S74.
25. Joshi R, Reingold A L, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med 2006; 3: e494.
26. Costa P A, Vieira M A M S, Mello F Q, Kritski A L, Souza S R G. Risco de transmissão nosocomial do Mycobacterium tuberculosis entre estudantes de Medicina da UFRJ nos dois primeiros anos do0 curso médico - resultados preliminares. J Bras Pneumol 2008; 34 (Suppl 1R): R 30. [Brazilian]
27. Muzzy de Souza G R. Tuberculose em profissionais em hospital géral. Análise do efeito booster e conversão do teste tuberculínico. [Tese de Doutorado]. Rio de Janeiro, Brazil: Universidade Federal do Rio de Janeiro, 2000: p 109. [Brazilian]
28. Cauthen G M, Snider D E Jr, Onorato I M. Boosting of tuberculin sensitivity among South-East Asian refugees. Am J Respir Crit Care Med 1994; 149: 1597-1600.
29. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992; 146: 752-756.
30. Moreno S, Blázquez R, Novoa A, et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Intern Med 2001; 161: 1760-1765.
31. Sepulveda R L, Ferrer X, Latrach C, Sorensen R U. The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990; 142: 24-28.
32. Kopanoff D E, Snider D E Jr, Caras G J. Isoniazid-related hepatitis: a US Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978; 117: 991-1001.
33. Bailey W C, Byrd R B, Glassroth J L, Hopewell P C, Reichman L B. Preventive treatment of tuberculosis. Chest 1985; 87 (Suppl 2): S128- S132.
34. Grindulis H, Baynham M I, Scott P H, Thompson R A, Wharton B A. Tuberculin response two years after BCG vaccination at birth. Arch Dis Child 1984; 59: 614-619.
35. Pereira S M, Bierrenbach A L, Dourado I, et al. Sensitivity and specificity of the BCG scar reading. Rev Saude Publica 2003; 37: 254-259.